无并发症急性阑尾炎的抗生素治疗:APPAC随机临床试验十年随访
APPAC多中心随机临床试验的十年观察性随访,在芬兰6家医院纳入530例经CT诊断的无并发症急性阑尾炎成人患者,随机分入阑尾切除术组(n=273)或抗生素组(n=257)。抗生素组10年真实阑尾炎复发率为37.8%(95%CI 31.6%-44.1%),累积阑尾切除率为44.3%(95%CI 38.2%-50.4%);抗生素组10年累积并发症率8.5%低于阑尾切除术组的27.4%(P<.001)。作者认为十年随访的复发与阑尾切除率支持将抗生素作为成人无并发症急性阑尾炎的一种选择。
要点
- 抗生素组10年真实阑尾炎复发率37.8%(95%CI 31.6%-44.1%),累积阑尾切除率44.3%(95%CI 38.2%-50.4%)。
- 10年累积并发症率抗生素组8.5% vs 阑尾切除术组27.4%(P<.001)。
- 两组生活质量未见显著差异(健康指数中位数均为1.0,P=.18)。
核心结论
- 在最初接受抗生素治疗的无并发症急性阑尾炎患者中,10年随访的复发率和阑尾切除率支持将抗生素作为成人无并发症急性阑尾炎的一种选择。
研究设计与样本
- APPAC多中心随机临床试验的十年观察性随访,2009年11月至2012年6月在芬兰6家医院纳入530例经计算机断层扫描诊断的无并发症急性阑尾炎成人患者(18-60岁),随机分入阑尾切除术组(n=273)或抗生素组(n=257),末次随访为2024年4月29日。
- 本分析聚焦评估抗生素组患者的10年阑尾炎复发率;干预为开腹阑尾切除术对比抗生素治疗(静脉厄他培南钠1 g/d共3天,随后口服左氧氟沙星500 mg每日一次和甲硝唑500 mg每日三次共7天)。
主要发现
- 10年随访时,抗生素组253/257例(98.4%)完成阑尾炎复发评估(中位年龄33岁;102例[40.3%]为女性),真实阑尾炎复发率(组织病理学诊断为阑尾炎)为37.8%(95%CI 31.6%-44.1%[87/230]),累积阑尾切除率为44.3%(95%CI 38.2%-50.4%[112/253])。
- 10年累积并发症率阑尾切除术组为27.4%(95%CI 21.6%-33.3%[62/226]),抗生素组为8.5%(95%CI 4.8%-12.1%[19/224])(P<.001)。
- 抗生素组与阑尾切除术组生活质量未见显著差异(387/530;两组健康指数中位值均为1.0[95%CI 1.0-1.0];P=.18)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Antibiotic therapy is effective and safe for uncomplicated acute appendicitis in adults, but randomized clinical trial results exceeding 5 years are missing. OBJECTIVE: To determine the 10-year appendicitis recurrence and appendectomy rate in patients with uncomplicated appendicitis treated with antibiotics. DESIGN, SETTING, AND PARTICIPANTS: Ten-year observational follow-up of patients in the Appendicitis Acuta (APPAC) multicenter randomized clinical trial comparing appendectomy with antibiotics at 6 Finnish hospitals from November 2009 to June 2012, where 530 patients (aged 18-60 years) with uncomplicated acute appendicitis diagnosed by computed tomography were randomly assigned to appendectomy (n = 273) or antibiotics (n = 257). Last follow-up was April 29, 2024. This current analysis focused on assessing the 10-year appendicitis recurrence rate among patients assigned to antibiotics. INTERVENTIONS: Open appendectomy vs antibiotics with intravenous ertapenem sodium (1 g/d) for 3 days followed by 7 days of oral levofloxacin (500 mg once daily) and metronidazole (500 mg 3 times/d). MAIN OUTCOMES AND MEASURES: Prespecified 10-year secondary end points included late (after 1 year) appendectomy and appendicitis recurrence rate after antibiotics and complications. Post hoc outcomes included the detection of possible appendiceal tumors among patients in the antibiotic group undergoing appendectomy or with an intact appendix using magnetic resonance imaging. Additional post hoc outcomes were quality of life and patient satisfaction. RESULTS: At 10-year follow-up, 253/257 patients (98.4%) randomized to receive antibiotics (median age, 33 years; 102 [40.3%] female) were assessed for appendicitis recurrence, with a true appendicitis recurrence rate (appendicitis at histopathology) of 37.8% (95% CI, 31.6%-44.1% [87/230]) and a cumulative appendectomy rate of 44.3% (95% CI, 38.2%-50.4% [112/253]). Overall, the 10-year cumulative complication rate in the group randomized to appendectomy was 27.4% (95% CI, 21.6%-33.3% [62/226]) and 8.5% (95% CI, 4.8%-12.1% [19/224]) in the group randomized to receive antibiotics (P < .001). There was no observed significant difference in quality of life between antibiotics and appendectomy (387/530; median health index value, 1.0 [95% CI, 1.0-1.0] for both groups; P = .18). CONCLUSIONS AND RELEVANCE: Among patients initially treated with antibiotics for uncomplicated acute appendicitis, the rate of recurrence and appendectomy at 10-year follow-up supports the use of antibiotics as an option for uncomplicated acute appendicitis in adult patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01022567.
引用
- Salminen P, Salminen R, Kallio J, et al. Antibiotic Therapy for Uncomplicated Acute Appendicitis: Ten-Year Follow-Up of the APPAC Randomized Clinical Trial. JAMA. 2026. PMID: 41563747. doi:10.1001/jama.2025.25921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。